Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by toinv261on Feb 24, 2016 5:07pm
216 Views
Post# 24591394

RVX Zenith and J Tull

RVX Zenith and J TullHi folks.

Just a quick comment. After Don gave the Zenith update and then the presentation down in the USA his backing away from the NASDAQ listing and non commital IPO section in the presentation I was reminded of a song by a 1970s rock group called Jethro Tull and one of their songs titled "Skating Away (on the thin ice of a new day)".

He pulled it off again. Got his presentation done without being challenged and has skated away from Zenith for another year. My bet is that there will not be an IPO until at least June of 2017 if at all.

I guess my 8 years of involvement in this stock has brought me to a reality regarding Don.

It looks like promising science. RVX and Zenith are like academic institutions and do not behave in any way like businesses.

GLTA because we will need it for sure.
Toinv
Bullboard Posts